Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sharpe

Showing results (31-40 of 213) with videos related to

Pageof 22
Sort By:
European Heart Journal|October 29, 2000
Prognostic stratification in heart failure: what's the point?H Oxenham, N Sharpe
European Heart Journal|September 1, 1996
The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after acute myocardial infarctionK Swedberg, N Sharpe
Journal of Cardiovascular Pharmacology|January 1, 1990
Future directions for randomized trials of cardiovascular disease prevention in hypertensive patientsS MacMahon, N Sharpe
Journal of the American College of Cardiology|December 29, 2000
Angiotensin-converting enzyme inhibitor treatment after myocardial infarction. A selective approach for maximum benefitH Oxenham, N Sharpe
The Medical Journal of Australia|April 1, 1991
Long-term antiplatelet therapy for the prevention of vascular diseaseS MacMahon, N Sharpe
Lancet (London, England)|September 15, 1998
Epidemiology of heart failure and ventricular dysfunctionN Sharpe, R Doughty
European Journal of Clinical Pharmacology|January 1, 1983
Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failureD N Sharpe, R Coxon
Australian and New Zealand Journal of Medicine|October 1, 1982
Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effectsD N Sharpe, R Coxon
Drugs & Aging|May 1, 1996
Optimal treatment of angina in older patientsR N Doughty, N Sharpe
Journal of Cardiovascular Risk|August 27, 1999
Effects of beta-blockers on symptoms and exercise tolerance in patients with heart failureR N Doughty, N Sharpe
Pageof 22

Showing results (31-40 of 213) with videos related to

Sort By:
Pageof 22
European Heart Journal|October 29, 2000
Prognostic stratification in heart failure: what's the point?H Oxenham, N Sharpe
European Heart Journal|September 1, 1996
The value of angiotensin converting enzyme inhibitors for the treatment of patients with left ventricular dysfunction, heart failure or after acute myocardial infarctionK Swedberg, N Sharpe
Journal of Cardiovascular Pharmacology|January 1, 1990
Future directions for randomized trials of cardiovascular disease prevention in hypertensive patientsS MacMahon, N Sharpe
Journal of the American College of Cardiology|December 29, 2000
Angiotensin-converting enzyme inhibitor treatment after myocardial infarction. A selective approach for maximum benefitH Oxenham, N Sharpe
The Medical Journal of Australia|April 1, 1991
Long-term antiplatelet therapy for the prevention of vascular diseaseS MacMahon, N Sharpe
Lancet (London, England)|September 15, 1998
Epidemiology of heart failure and ventricular dysfunctionN Sharpe, R Doughty
European Journal of Clinical Pharmacology|January 1, 1983
Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failureD N Sharpe, R Coxon
Australian and New Zealand Journal of Medicine|October 1, 1982
Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effectsD N Sharpe, R Coxon
Drugs & Aging|May 1, 1996
Optimal treatment of angina in older patientsR N Doughty, N Sharpe
Journal of Cardiovascular Risk|August 27, 1999
Effects of beta-blockers on symptoms and exercise tolerance in patients with heart failureR N Doughty, N Sharpe
Pageof 22